Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
about
MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass indexPrognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastomaQuality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRMA 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues.Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma.Loss of expression and promoter methylation of SLIT2 are associated with sessile serrated adenoma formation.Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes.Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant gliomaDNA methylation profiles and biomarkers of oral squamous cell carcinoma.E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.The epigenetic landscape of oral squamous cell carcinomaAssessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in GlioblastomaAnalysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers.Molecular sputum analysis for the diagnosis of lung cancerInvestigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing.DNA methylation in circulating tumour DNA as a biomarker for cancer.Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.DNA methylation testing and marker validation using PCR: diagnostic applications.Detection of MGMT promoter methylation in glioblastoma using pyrosequencing.Detection of MGMT promoter methylation in glioblastoma using pyrosequencingEpigenetic biomarkers in the diagnosis of ovarian cancer.Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2.Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid.UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer.Analysis of epigenetic modifications of DNA in human cells.CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer.[The next generation sequencing technology and its application in cancer research].Pyrosequencing Analysis of Promoter Methylation in Meningioma
P2860
Q24628888-20A29697-3B73-48B3-BE97-5C909A9F7D52Q28731328-9566911A-66ED-4DF0-AA4B-421CE324A23BQ33520069-52C77346-974D-407A-8BB9-AB1F51614AF9Q33899068-B4D3BB54-6F1E-4D3B-A80A-52D246AF458EQ34654655-22A3EFFC-A254-4513-8024-4AA7F17DCC7FQ34720314-4F794548-C6BD-416D-9EFA-F2ACB78C1B3EQ36050701-8C0FE580-5F16-4FE2-9F04-429704418757Q36135415-2A24E461-EC5B-4BF2-A65E-C9704AA4D020Q36213267-8EAF9716-31CC-45AA-812C-7BFD5BE6B63BQ36414343-8A377291-CD89-44CA-940B-29B94119228DQ36594150-FB84BB32-3FBA-4C66-ACFA-8D7511BC0F56Q36648767-8AA55B51-D071-4B41-980E-82749BC5F487Q36836937-2061FECD-BD97-4D4A-AFCB-26431A7AA773Q36844969-67603C3E-FD64-4E39-969E-C3A9B05C50C0Q37081967-0B5A8A74-91E7-4996-81FA-07BD180A4345Q37201885-2D894158-5210-409A-89E8-790F568FE9CBQ37280956-56297BF8-E80E-44C8-9855-05AEE7B6A223Q37453787-52E2EBDA-2B32-4854-9F88-5D498D17A588Q37963517-14141C77-08F9-4A0E-B93C-6637A49F9FDEQ38875094-5FE8ABF8-BCBC-4FA5-845C-7B37962A9355Q38901697-87B07534-A40D-416E-A546-630C680FC73DQ39453522-B3625249-D1CC-4625-840C-5B6C06C91B00Q39528057-9E1C079C-E69E-495F-86AB-785729E41675Q42738436-ECF6A00B-1CC4-44D1-AC00-6CFA0C981879Q51022828-B030321C-E1F4-47A3-9D01-63B4DF6D3184Q53265228-9E198D81-1573-4142-842C-C0DF35F625CAQ54263329-A4F993DC-2B83-49D7-8DD4-E334620DD320Q55400516-D54223EA-407A-47DB-B245-3DDFF9D128C6Q55443705-0DEC1EAB-DAE4-4085-B193-AE3590CAFEFDQ58766022-F5F7530D-E37E-4874-B932-02A392FA0FCC
P2860
Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Methylation enrichment pyroseq ...... validation by pyrosequencing.
@en
type
label
Methylation enrichment pyroseq ...... validation by pyrosequencing.
@en
prefLabel
Methylation enrichment pyroseq ...... validation by pyrosequencing.
@en
P2093
P2860
P356
P1476
Methylation enrichment pyroseq ...... validation by pyrosequencing.
@en
P2093
Emily K Akufo-Tetteh
Janet M Risk
Richard J Shaw
Triantafillos Liloglou
P2860
P356
10.1093/NAR/GKL424
P577
2006-06-28T00:00:00Z